» Articles » PMID: 25143193

Risk Factors for Enterococcal Infection and Colonization by Vancomycin-resistant Enterococci in Critically Ill Patients

Overview
Journal Infection
Date 2014 Aug 22
PMID 25143193
Citations 43
Authors
Affiliations
Soon will be listed here.
Abstract

Purpose: Vancomycin-Resistant Enterococci (VRE) are important causes of Intensive Care Unit (ICU) infections. Our goal was to identify the prevalence and risk factors for VRE colonization upon ICU admission and during ICU stay, as well as, their impact in enterococcal infection including vancomycin-susceptible cases (VSE).

Methods: A prospective study regarding patients admitted in ICU (n = 497) was conducted during a 24-month period. Rectal swabs were collected upon admission and during hospitalization and inoculated onto selective medium. Enterococci were phenotypically characterized. van genes were investigated by PCR and clones were identified by Pulsed-Field Gel Electrophoresis and Multilocus Sequence Typing. Epidemiologic data were collected from the ICU database.

Results: Risk factors for VRE carriage upon ICU admission (71/497) were: duration of previous hospitalization, glycopeptide administration, chronic heart failure, malignancy, insulin-dependent diabetes mellitus, and previous enterococcal infection (VRE and/or VSE). Risk factors for VRE colonization during ICU stay (36/250) were: quinolone administration, chronic obstructive pulmonary disease, chronic renal failure, and number of VRE-positive patients in nearby beds. Risk factors for enterococcal infection during ICU stay (15/284), including VRE and VSE cases, were: administration of third- or fourth-generation cephalosporins, cortisone use before ICU admission and VRE colonization, whereas, enteral nutrition was a protective factor.

Conclusions: Previous VRE colonization and antibiotic usage are essential parameters for enterococcal infection (by VRE or VSE) during ICU stay. Previous enterococcal infection, co-morbidities and antibiotic usage are associated with VRE colonization upon ICU admission, whereas, patient to patient transmission, co-morbidities and antibiotic usage constitute risk factors for VRE colonization during ICU hospitalization.

Citing Articles

Timing and clinical risk factors for early acquisition of gut pathogen colonization with multidrug resistant organisms in the intensive care unit.

Shamalov L, Heath M, Lynch E, Green D, Gomez-Simmonds A, Freedberg D Gut Pathog. 2024; 16(1):10.

PMID: 38383457 PMC: 10880254. DOI: 10.1186/s13099-024-00605-z.


Vancomycin Resistant Enterococci Prevalence, Antibiotic Susceptibility Patterns and Colonization Risk Factors Among HIV-Positive Patients in Health-Care Facilities in Debre Berhan Town, Ethiopia.

Zike M, Ahmed A, Hailu A, Hussien B Infect Drug Resist. 2024; 17:17-29.

PMID: 38192330 PMC: 10771780. DOI: 10.2147/IDR.S440479.


Characterization of a Tigecycline-, Linezolid- and Vancomycin-Resistant Clinical Enteroccoccus faecium Isolate, Carrying vanA and vanB Genes.

Wardal E, Zabicka D, Skalski T, Kubiak-Pulkowska J, Hryniewicz W, Sadowy E Infect Dis Ther. 2023; 12(11):2545-2565.

PMID: 37821741 PMC: 10651664. DOI: 10.1007/s40121-023-00881-3.


Antimicrobial stewardship in the intensive care unit.

Ture Z, Guner R, Alp E J Intensive Med. 2023; 3(3):244-253.

PMID: 37533805 PMC: 10391567. DOI: 10.1016/j.jointm.2022.10.001.


Contact tracing for vancomycin-resistant Enterococcus faecium (VRE): evaluation of the Dutch policy of quintuple screening cultures.

Wammes L, Voor In t Holt A, Klaassen C, Vos M, Verkaik N, Severin J Eur J Clin Microbiol Infect Dis. 2023; 42(8):993-999.

PMID: 37351725 PMC: 10345005. DOI: 10.1007/s10096-023-04632-7.


References
1.
Damani A, Klapsa D, Panopoulou M, Spiliopoulou I, Pantelidi K, Malli E . A newly described vancomycin-resistant ST412 Enterococcus faecium predominant in Greek hospitals. Eur J Clin Microbiol Infect Dis. 2009; 29(3):329-31. DOI: 10.1007/s10096-009-0847-9. View

2.
Bell J, Turnidge J, Coombs G, OBrien F . Emergence and epidemiology of vancomycin-resistant enterococci in Australia. Commun Dis Intell. 1998; 22(11):249-52. View

3.
Sofianou D, Pournaras S, Giosi M, Polyzou A, Maniatis A, Tsakris A . Substantially increased faecal carriage of vancomycin-resistant enterococci in a tertiary Greek hospital after a 4 year time interval. J Antimicrob Chemother. 2004; 54(1):251-4. DOI: 10.1093/jac/dkh293. View

4.
Batistao D, Gontijo-Filho P, Conceicao N, Oliveira A, Ribas R . Risk factors for vancomycin-resistant enterococci colonisation in critically ill patients. Mem Inst Oswaldo Cruz. 2012; 107(1):57-63. DOI: 10.1590/s0074-02762012000100008. View

5.
Bonten M, Slaughter S, Ambergen A, Hayden M, van Voorhis J, Nathan C . The role of "colonization pressure" in the spread of vancomycin-resistant enterococci: an important infection control variable. Arch Intern Med. 1998; 158(10):1127-32. DOI: 10.1001/archinte.158.10.1127. View